Mersana Therapeutics, Inc.
MRSN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $108 | $175 | $129 | $178 |
| Short-Term Investments | $27 | $35 | $152 | $0 |
| Receivables | $0 | $0 | $30 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $5 | $9 | $11 |
| Total Curr. Assets | $137 | $214 | $319 | $189 |
| Property Plant & Equip (Net) | $7 | $12 | $14 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $1 | $2 |
| Total NC Assets | $8 | $12 | $15 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $145 | $226 | $334 | $206 |
| Liabilities | – | – | – | – |
| Payables | $4 | $7 | $14 | $12 |
| Short-Term Debt | $13 | $2 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $22 | $28 | $31 | $4 |
| Other Curr. Liab. | $12 | $14 | $1 | $22 |
| Total Curr. Liab. | $62 | $64 | $92 | $48 |
| LT Debt | $11 | $23 | $25 | $25 |
| Deferred Rev, NC | $79 | $97 | $117 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $1 |
| Total NC Liab. | $92 | $126 | $151 | $37 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $8 | $11 | $14 |
| Total Liabilities | $154 | $189 | $242 | $84 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$896 | -$826 | -$655 | -$450 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$10 | $37 | $92 | $122 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $145 | $226 | $334 | $206 |
| Net Debt | -$84 | -$149 | -$104 | -$153 |